Five Digital Health Investments Every Healthcare CEO in India Should Prioritise Before 2027

India's digital health sector was valued at USD 6.3 billion in 2021 and is projected to reach USD 30 billion by 2027, a compound growth rate of roughly 28.5%. That trajectory changes what digital investment means for a CEO: capital-allocation and governance decisions that determine market position. This is no longer a debate about whether digital transformation matters to healthcare delivery; that question has been settled. The debate that remains, and the one CEOs are actually being tested on, is sequencing: which investments compound in value the earliest, which carry the sharpest downside if delayed, and which decisions cannot credibly sit with anyone below the CEO's desk. The evidence on all three points has become considerably clearer over the past two years.

2027 is the point at which several policy and market cycles converge: India's Ayushman Bharat Digital Mission (ABDM) is designed to reach system-wide adoption, global AI-in-healthcare investment will have compounded at 44.2% annually since 2019, and India's Digital Personal Data Protection (DPDP) Act moves from legislation to enforced compliance. And globally, the cost of getting cybersecurity and AI governance wrong has already been demonstrated at a scale no CEO can dismiss. Five investment areas sit at the intersection of all three cycles: policy readiness, market growth, and demonstrated risk. What follows is the evidence for each: what the data shows about acting now, and what the data shows happens to systems that don't.

Unlock the Future of Digital Health — Free for 60 Days!

Join DHN Plus and access exclusive news, intelligence reports, and deep-dive research trusted by healthtech leaders.

Already a subscriber? Log in

Subscribe Now @ ₹499.00

Stay tuned for more such updates on Digital Health News